NO20003853L - Compounds for therapy and diagnosis of lung cancer and methods for their use - Google Patents
Compounds for therapy and diagnosis of lung cancer and methods for their useInfo
- Publication number
- NO20003853L NO20003853L NO20003853A NO20003853A NO20003853L NO 20003853 L NO20003853 L NO 20003853L NO 20003853 A NO20003853 A NO 20003853A NO 20003853 A NO20003853 A NO 20003853A NO 20003853 L NO20003853 L NO 20003853L
- Authority
- NO
- Norway
- Prior art keywords
- diagnosis
- therapy
- compounds
- methods
- lung cancer
- Prior art date
Links
- 206010058467 Lung neoplasm malignant Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 201000005202 lung cancer Diseases 0.000 title 1
- 208000020816 lung neoplasm Diseases 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/117—Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1502998A | 1998-01-28 | 1998-01-28 | |
| US1502298A | 1998-01-28 | 1998-01-28 | |
| US4082898A | 1998-03-18 | 1998-03-18 | |
| US4083198A | 1998-03-18 | 1998-03-18 | |
| US12219198A | 1998-07-23 | 1998-07-23 | |
| US12219298A | 1998-07-23 | 1998-07-23 | |
| US21924598A | 1998-12-22 | 1998-12-22 | |
| PCT/US1999/001642 WO1999038973A2 (en) | 1998-01-28 | 1999-01-26 | Compounds for therapy and diagnosis of lung cancer and methods for their use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20003853D0 NO20003853D0 (en) | 2000-07-27 |
| NO20003853L true NO20003853L (en) | 2000-09-27 |
Family
ID=27567530
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20003853A NO20003853L (en) | 1998-01-28 | 2000-07-27 | Compounds for therapy and diagnosis of lung cancer and methods for their use |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1051489A2 (en) |
| JP (1) | JP2002516659A (en) |
| KR (1) | KR20010034436A (en) |
| CN (1) | CN1292029A (en) |
| AR (1) | AR014514A1 (en) |
| AU (1) | AU2344399A (en) |
| BR (1) | BR9907259A (en) |
| CA (1) | CA2319117A1 (en) |
| ID (1) | ID27813A (en) |
| IL (1) | IL137417A0 (en) |
| NO (1) | NO20003853L (en) |
| WO (1) | WO1999038973A2 (en) |
| ZA (1) | ZA99693B (en) |
Families Citing this family (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6960570B2 (en) | 1998-03-18 | 2005-11-01 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| US6696247B2 (en) | 1998-03-18 | 2004-02-24 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
| US6821518B1 (en) | 1998-03-18 | 2004-11-23 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
| US6531315B1 (en) | 1998-03-18 | 2003-03-11 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| US6426072B1 (en) | 2000-08-02 | 2002-07-30 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| US6482597B1 (en) | 1999-12-17 | 2002-11-19 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
| US6312695B1 (en) | 1998-03-18 | 2001-11-06 | Corixa Corporation | Compounds and methods for therapy of lung cancer |
| US6706262B1 (en) | 1998-03-18 | 2004-03-16 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
| US7258860B2 (en) | 1998-03-18 | 2007-08-21 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| US6737514B1 (en) | 1998-12-22 | 2004-05-18 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| US6518256B1 (en) | 1998-03-18 | 2003-02-11 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
| US7579160B2 (en) | 1998-03-18 | 2009-08-25 | Corixa Corporation | Methods for the detection of cervical cancer |
| US6660838B1 (en) | 1998-03-18 | 2003-12-09 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
| US7049063B2 (en) | 1998-03-18 | 2006-05-23 | Corixa Corporation | Methods for diagnosis of lung cancer |
| EP0987552A3 (en) * | 1998-08-31 | 2000-06-07 | Pfizer Products Inc. | Diarylsulfonylurea binding proteins |
| EP1526383A3 (en) * | 1998-08-31 | 2005-11-16 | Pfizer Products Inc. | Diarylsulfonylurea binding proteins |
| AU766809B2 (en) * | 1998-10-28 | 2003-10-23 | Rigel Pharmaceuticals, Inc. | Novel compositions and methods of screening for T-cell and B-cell activation modulators |
| US6709855B1 (en) | 1998-12-18 | 2004-03-23 | Scios, Inc. | Methods for detection and use of differentially expressed genes in disease states |
| AU2055300A (en) * | 1998-12-18 | 2000-07-03 | Scios Inc. | Methods for detection and use of differentially expressed genes in disease states |
| WO2000046370A1 (en) * | 1999-02-04 | 2000-08-10 | Board Of Trustees Of The University Of Illinois | P37ing1 compositions and methods of use |
| AU772103B2 (en) | 1999-02-19 | 2004-04-08 | Zymogenetics Inc. | Inhibitors for use in hemostasis and immune function |
| US6544946B1 (en) | 1999-02-19 | 2003-04-08 | Zymogenetics, Inc. | Inhibitors for use in hemostasis and immune function |
| HK1045332A1 (en) * | 1999-04-02 | 2002-11-22 | Corixa Corporation | Compounds for therapy and diagnosis of lung cancer and methods for their use |
| US6444425B1 (en) | 1999-04-02 | 2002-09-03 | Corixa Corporation | Compounds for therapy and diagnosis of lung cancer and methods for their use |
| US6759508B2 (en) | 2000-09-01 | 2004-07-06 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| HK1049848A1 (en) * | 1999-04-02 | 2003-05-30 | 科里克萨有限公司 | Compounds and methods for therapy and diagnosis of lung cancer |
| US6509448B2 (en) | 1999-06-30 | 2003-01-21 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| US6686447B1 (en) | 1999-06-30 | 2004-02-03 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| US6914132B1 (en) | 1999-06-30 | 2005-07-05 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| US6667154B1 (en) | 1999-06-30 | 2003-12-23 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| US6858204B2 (en) | 1999-06-30 | 2005-02-22 | Corxia Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| CA2380873A1 (en) | 1999-06-30 | 2001-01-04 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| US6504010B1 (en) | 1999-06-30 | 2003-01-07 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| US20030125245A1 (en) | 1999-06-30 | 2003-07-03 | Tongtong Wang | Compositions and methods for therapy and diagnosis of lung cancer |
| US6746846B1 (en) | 1999-06-30 | 2004-06-08 | Corixa Corporation | Methods for diagnosing lung cancer |
| US20030211510A1 (en) | 1999-06-30 | 2003-11-13 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| CA2309313A1 (en) * | 1999-08-05 | 2001-02-05 | Board Of Trustees Of The University Of Arkansas | Stimulation of the immune response by human dendritic cell manipulation |
| AU7832700A (en) * | 1999-09-23 | 2001-04-24 | Corixa Corporation | Ovarian tumor antigen and methods of use therefor |
| CA2491610A1 (en) * | 1999-12-01 | 2001-06-07 | Kevin P. Baker | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| EP1272511A2 (en) * | 2000-04-14 | 2003-01-08 | Incyte Genomics, Inc. | Molecules associated with human reproduction |
| EP1366157A2 (en) * | 2000-06-29 | 2003-12-03 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| EP1343886A2 (en) * | 2000-07-11 | 2003-09-17 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| WO2002006455A2 (en) * | 2000-07-19 | 2002-01-24 | Bayer Aktiengesellschaft | Regulation of human airway trypsin protease-like enzyme |
| TWI317380B (en) * | 2000-08-28 | 2009-11-21 | Teijin Ltd | Airway-specific trypsin-like enzymes and method of using the same |
| EP1421190A2 (en) | 2001-01-16 | 2004-05-26 | Genset | Metabolic gene polynucleotides and polypeptides and uses thereof |
| GB0101300D0 (en) * | 2001-01-18 | 2001-02-28 | Univ Cambridge Tech | Primordial germ cell genes |
| US7226994B2 (en) | 2001-01-18 | 2007-06-05 | Cambridge University Technical Services Limited | Cell surface expressed marker of pluripotency |
| US20050085627A1 (en) | 2001-06-21 | 2005-04-21 | Youming Zhang | Atopy |
| US20040081653A1 (en) * | 2002-08-16 | 2004-04-29 | Raitano Arthur B. | Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer |
| AU2007216892B2 (en) * | 2002-08-16 | 2011-02-10 | Agensys, Inc. | Nucleic acids and corresponding proteins entitled 273P4B7 useful in treatment and detection of cancer |
| EP1583548A4 (en) * | 2002-12-10 | 2007-10-17 | Epimmune Inc | HLA-A1, A2 -A3, -A24, -B7 AND B44TUMOR ASSOCIATED ANTIGENPEPTIDES AND COMPOSITIONS |
| CA2589782A1 (en) * | 2004-11-30 | 2006-06-08 | Veridex Llc | Lung cancer prognostics |
| WO2007047764A2 (en) | 2005-10-17 | 2007-04-26 | Sloan Kettering Institute For Cancer Research | Wt1 hla class ii-binding peptides and compositions and methods comprising same |
| EP3117836A1 (en) | 2006-04-10 | 2017-01-18 | Sloan Kettering Institute For Cancer Research | Immunogenic wt-1 peptides and uses thereof |
| EP2061900A2 (en) * | 2006-08-25 | 2009-05-27 | Oncotherapy Science, Inc. | Prognostic markers and therapeutic targets for lung cancer |
| US20110236314A1 (en) * | 2008-09-12 | 2011-09-29 | Cancer Research Initiatives Foundation | Method of detection and diagnosis of oral and nasopharyngeal cancers |
| CN101891802B (en) * | 2009-08-11 | 2011-11-16 | 武汉凯泰新生物技术有限公司 | Polypeptide or derivative product for treating or preventing cancer and application thereof |
| CN101921313B (en) * | 2010-04-07 | 2012-02-29 | 武汉凯泰新生物技术有限公司 | Polypeptide for curing or preventing cancer or derivative product and application thereof |
| GB201104286D0 (en) * | 2011-03-15 | 2011-04-27 | Randox Lab Ltd | Glutathione S-transferase omega 1 wild type specific antibody |
| CN108456249B (en) * | 2011-09-09 | 2021-09-03 | 转基因股份有限公司 | Antibody of variant alpha-actinin-4 |
| HK1204261A1 (en) | 2012-01-13 | 2015-11-13 | Memorial Sloan Kettering Cancer Center | Immunogenic wt-1 peptides and methods of use thereof |
| US10815273B2 (en) | 2013-01-15 | 2020-10-27 | Memorial Sloan Kettering Cancer Center | Immunogenic WT-1 peptides and methods of use thereof |
| PT2945647T (en) | 2013-01-15 | 2020-11-26 | Memorial Sloan Kettering Cancer Center | Immunogenic wt-1 peptides and methods of use thereof |
| US20170319722A1 (en) * | 2016-04-04 | 2017-11-09 | Indi Molecular, Inc. | Cd8-specific capture agents, compositions, and methods of using and making |
| JP7210029B2 (en) * | 2016-11-16 | 2023-01-23 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Inhibitor of CRISPR-Cas9 |
| CN110669104B (en) * | 2019-10-30 | 2021-11-05 | 上海交通大学 | A group of markers derived from human peripheral blood mononuclear cells and their applications |
| CN112500467B (en) * | 2020-12-14 | 2022-05-24 | 上海交通大学 | Bioactive peptide RRECPSDECGAGVF, and preparation method and application thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5589579A (en) * | 1994-07-19 | 1996-12-31 | Cytoclonal Pharmaceutics, Inc. | Gene sequence and probe for a marker of non-small cell lung carinoma |
| US5633161A (en) * | 1995-03-29 | 1997-05-27 | Millennium Pharmaceuticals, Inc. | Murine gene fomy030 coding for tumor progression inhibitor |
-
1999
- 1999-01-20 ID IDW20001646A patent/ID27813A/en unknown
- 1999-01-26 CA CA002319117A patent/CA2319117A1/en not_active Abandoned
- 1999-01-26 JP JP2000529432A patent/JP2002516659A/en not_active Withdrawn
- 1999-01-26 BR BR9907259-9A patent/BR9907259A/en not_active Application Discontinuation
- 1999-01-26 KR KR1020007008209A patent/KR20010034436A/en not_active Withdrawn
- 1999-01-26 IL IL13741799A patent/IL137417A0/en unknown
- 1999-01-26 CN CN99803446A patent/CN1292029A/en active Pending
- 1999-01-26 EP EP99903417A patent/EP1051489A2/en not_active Withdrawn
- 1999-01-26 WO PCT/US1999/001642 patent/WO1999038973A2/en not_active Ceased
- 1999-01-26 AU AU23443/99A patent/AU2344399A/en not_active Abandoned
- 1999-01-28 ZA ZA9900693A patent/ZA99693B/en unknown
- 1999-01-28 AR ARP990100346A patent/AR014514A1/en unknown
-
2000
- 2000-07-27 NO NO20003853A patent/NO20003853L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1292029A (en) | 2001-04-18 |
| ZA99693B (en) | 1999-10-21 |
| WO1999038973A2 (en) | 1999-08-05 |
| BR9907259A (en) | 2002-01-22 |
| AR014514A1 (en) | 2001-02-28 |
| JP2002516659A (en) | 2002-06-11 |
| CA2319117A1 (en) | 1999-08-05 |
| EP1051489A2 (en) | 2000-11-15 |
| ID27813A (en) | 2001-04-26 |
| WO1999038973A3 (en) | 1999-12-09 |
| AU2344399A (en) | 1999-08-16 |
| IL137417A0 (en) | 2001-07-24 |
| NO20003853D0 (en) | 2000-07-27 |
| KR20010034436A (en) | 2001-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20003853L (en) | Compounds for therapy and diagnosis of lung cancer and methods for their use | |
| NO20016427D0 (en) | Compositions and Methods for the Treatment of Diagnosis of Lung Cancer | |
| NO20010196L (en) | Compositions and Methods for Therapy and Diagnosis of Prostate Cancer | |
| HUP0200760A2 (en) | Compounds and methods for therapy and diagnosis of lung cancer | |
| NO20024972L (en) | Mixtures and Methods for Therapy and Diagnosis of Breast Cancer | |
| AU4185100A (en) | Compounds for therapy and diagnosis of lung cancer and methods for their use | |
| NO20023402D0 (en) | Mixtures and Methods for the Treatment and Diagnosis of Prostate Cancer | |
| PL366626A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
| NO20030714D0 (en) | Mixtures and Methods for the Treatment and Diagnosis of HER-2 / NEU-Associated Malignancies | |
| NO20010882L (en) | Therapies for the treatment of lung diseases | |
| NO20014769D0 (en) | Preparation for the treatment and diagnosis of breast cancer and methods for its use | |
| NO995690D0 (en) | Compounds for the diagnosis of tuberculosis and methods for their use | |
| NO971015L (en) | Compounds and Methods for the Treatment of Cancer | |
| DE50011194D1 (en) | Medical instrument for the preparation of tissue | |
| NO986089D0 (en) | Methods and preparations for the treatment of tumors, tumor-related diseases and o | |
| AU2002218770A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
| NO994932D0 (en) | Mixtures and Procedures for the Treatment and Diagnosis of Breast Cancer | |
| AU2002311909A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
| EP1446013A4 (en) | COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF LUNG CANCER | |
| NO20014804D0 (en) | Compounds for immunotherapy and diagnosis of breast cancer and methods for their use | |
| NO20025594L (en) | Mixtures and Methods for Therapy and Diagnosis of Breast Cancer | |
| AU2003230849A8 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
| ATE396265T1 (en) | COMPOSITIONS AND METHODS FOR THERAPY AND DIAGNOSIS OF LUNG CANCER | |
| NO20014805D0 (en) | Mixtures and Methods for Treating and Diagnosing Breast Cancer | |
| AU2001273127A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer |